✦ LIBER ✦

A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma

✍ Scribed by Nizar M. Tannir; Elizabeth Plimack; Chaan Ng; Pheroze Tamboli; Nebiyou B. Bekele; Lianchun Xiao; Lisa Smith; Zita Lim; Lance Pagliaro; John Araujo; Ana Aparicio; Surena Matin; Christopher G. Wood; Eric Jonasch

Book ID: 118440888
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 180 KB
Volume: 62
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2012.06.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 trial of everolimus plus sunitin

Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma

✍ Ana M. Molina; Darren R. Feldman; Martin H. Voss; Michelle S. Ginsberg; Michael 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

Phase II trial of topotecan in patients

Phase II trial of topotecan in patients with advanced renal cell carcinoma

✍ Teresa Murray Law; David H. Ilson; Robert J. Motzer 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 159 KB

Phase 2 trial of linifanib (ABT-869) in

Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure

✍ Nizar M. Tannir; Yu-Ning Wong; Christian K. Kollmannsberger; Marc S. Ernstoff; D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Phase II trial of Didemnin B in patients

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma

✍ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell

Phase II trial of ZD1839 (IRESSA™) in pa

Phase II trial of ZD1839 (IRESSA™) in patients with advanced renal cell carcinoma

✍ Beverly Drucker; Jennifer Bacik; Michelle Ginsberg; Stephanie Marion; Paul Russo 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 58 KB

Phase 1 dose-escalation trial of tremeli

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Mark Stein; Pat Shannon; Simantini Eddy; Allison Tyler; Joe J. St 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views